Two regulatory worlds, one molecule
Most comparisons here set a research chemical against a prescription medicine. GHK-Cu needs a third column, because it already lives inside a regulated framework that is not the medicines one.
As a cosmetic ingredient it appears in finished products subject to cosmetic regulation: labelling requirements, ingredient disclosure, and a manufacturer with an address. As a research chemical in an injection vial it sits outside all of that.
Same molecule, two supply chains, and only one of them has any oversight attached. That is the comparison worth making, and it is not the usual one.
What the registry holds
Three records come back under the name. NCT05932732 is a completed Phase 4 study of 27 participants from the Austin Institute for Clinical Research, assessing facial skin quality, hydration and skin barrier across three HydraFacial treatments. NCT07706361 is not yet recruiting, 100 participants, sponsored by LifeWave, and examines that company's X39 patch and its effect on circulating GHK and GHK-Cu.
The third is filed by a sponsor whose registry records do not hold up on inspection, and it is not cited here.
So the registered evidence concerns a facial procedure and a patch. Neither involves injecting the compound, which is how it is predominantly sold in this market.
Why the route gap matters more than usual
A pharmacy dispensing a medicine hands over a product whose route of administration was part of what got approved. Route is not a detail bolted on afterwards; it determines exposure, distribution and what the safety data even applies to.
The published GHK-Cu record is about a copper complex delivered to the skin surface. An injected preparation is a different exposure entirely, and no study in the registry or the literature bridges the two.
A ghk cu dosage chart for injection therefore has no approved label and no registered trial to restate. It can honestly report what topical work used. Presenting injection quantities without saying where they came from is the step that would never survive the documentation a pharmacy route requires.